References
1.
American Diabetes Association Professional
Practice Committee. 2. Classification and Diagnosis
of Diabetes: Standards of Medical Care in Diabetes—2022. Diabetes
Care [Internet] 2021;45(Supplement_1):S17–38. Available from: https://doi.org/10.2337/dc22-S002
2.
Bliddal M, Broe A, Pottegård A, Olsen J,
Langhoff-Roos J. The danish medical birth register. European Journal of
Epidemiology [Internet] 2018;33(1):27–36. Available from: https://doi.org/10.1007/s10654-018-0356-1
3.
Sun
H, Saeedi P, Karuranga S, et al. IDF diabetes atlas: Global, regional
and country-level diabetes prevalence estimates for 2021 and projections
for 2045. Diabetes Research and Clinical Practice [Internet]
2022;183:109119. Available from: https://www.sciencedirect.com/science/article/pii/S0168822721004782
4.
Green A, Hede SM, Patterson CC, et al. Type 1 diabetes in
2017: Global estimates of incident and prevalent cases in children and
adults. Diabetologia 2021;64(12):2741–50.
5.
Fox
MP, Lash TL, Bodnar LM. Common misconceptions about validation studies.
International Journal of Epidemiology [Internet] 2020;49(4):1392–6.
Available from: https://doi.org/10.1093/ije/dyaa090
6.
Pettersson S, Hadziabdic E, Marklund H, Hjelm
K. Lower knowledge about
diabetes among foreign-born compared to swedish-born persons with
diabetes-a descriptive study. Nurs Open 2019;6(2):367–76.
7.
Hussen HI, Yang D, Cnattingius S, Moradi T.
Type i diabetes among children and young adults: The role of country of
birth, socioeconomic position and sex. Pediatric Diabetes [Internet]
2013;14(2):138–48. Available from: https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1399-5448.2012.00904.x
8.
Neu
A, Willasch A, Ehehalt S, Kehrer M, Hub R, Ranke MB. Diabetes incidence in children
of different nationalities: An epidemiological approach to the
pathogenesis of diabetes. Diabetologia 2001;44 Suppl 3:B21–6.
10.
Eurostat. Migrant
integration statistics [Internet]. {2022, last accessed 7 Feb
2023};Available from: https://ec.europa.eu/eurostat/statistics-explained/index.php?title=Migrant_integration_statistics
11.
Eurostat. Population
structure and ageing [Internet]. {2022, last accessed 7 Feb
2023};Available from: https://ec.europa.eu/eurostat/statistics-explained/index.php?title=Population_structure_and_ageing
12.
Eurostat. Ageing Europe -
statistics on health and disability [Internet]. {2022, last
accessed 7 Feb 2023};Available from: https://ec.europa.eu/eurostat/statistics-explained/index.php?title=Ageing_Europe_-_statistics_on_health_and_disability
13.
The
International Organization for Standardization. ISO
15189: Medical laboratories — Requirements for quality and
competence [Internet]. {2022, last accessed 7 Feb 2023};Available
from: https://www.iso.org/standard/76677.html
14.
DEFACTUM: Social & Health Services and
Labour Market. DEFACTUM: Population Health Surveys
[Internet]. {2022, last accessed 7 Feb 2023};Available from: https://www.defactum.net/research-areas/bif/
15.
Wells, D. Wikipedia
Commons: Risk Ratio vs Odds Ratio.svg [Internet]. {2022, last
accessed 7 Feb 2023};Available from: https://commons.wikimedia.org/w/index.php?curid=100175653
16.
Dansk Selskab for Almen Medicin [English: The
Danish College of General Practitioners]. Type
2-diabetes - opfølgning og behandling [English: Type 2 diabetes -
follow-up and treatment] [Internet]. {2019; last accessed on 7
Feb 2023};Available from: https://vejledninger.dsam.dk/type2/
17.
Dansk Selskab for Almen Medicin [English: The
Danish College of General Practitioners]. Type
2-diabetes - et metabolisk syndrom [English: Type 2 diabetes - a
metabolic syndrome] [Internet]. {2012; last accessed on 7 Feb
2023};Available from: https://vejledninger.dsam.dk/media/files/20/type-2-diabetes-2012-med-links.pdf
18.
Dansk Selskab for Almen Medicin [English: The
Danish College of General Practitioners]. Type
2-diabetes i almen praksis - en evidensbaseret vejledning [English: Type
2 diabetes in general practice - an evidence-based guideline]
[Internet]. {2004; last accessed on 7 Feb 2023};Available from: https://vejledninger.dsam.dk/media/files/20/type_2_diabetes_2004_rettet.pdf
19.
Dansk Selskab for Almen Medicin & Dansk
Endokrinologisk Selskab [English: The Danish College of General
Practitioners & The Danish Endocrine Society. Farmakologisk behandling af type 2-diabetes [English:
Pharmacological treatment of type 2 diabetes] [Internet]. {2022;
2023 revision};Available from: https://vejledninger.dsam.dk/fbv-t2dm/
20.
Lasota AN, Overvad K, Eriksen HH, Tjonneland A,
Schmidt EB, Gronholdt MM. Validity of peripheral
arterial disease diagnoses in the danish national patient registry.
Eur J Vasc Endovasc Surg 2017;53(5):679–85.
21.
Lühdorf P, Overvad K, Schmidt EB, Johnsen SP,
Bach FW. Predictive value of stroke discharge diagnoses in the danish
national patient register. Scandinavian Journal of Public Health
[Internet] 2017;45(6):630–6. Available from: https://doi.org/10.1177/1403494817716582
22.
Sundboll J, Adelborg K, Munch T, et al. Positive predictive
value of cardiovascular diagnoses in the danish national patient
registry: A validation study. BMJ Open 2016;6(11):e012832.
23.
Haller H, Ito S, Izzo JL, et al. Olmesartan for
the delay or prevention of microalbuminuria in type 2 diabetes. New
England Journal of Medicine [Internet] 2011;364(10):907–17. Available
from: https://doi.org/10.1056/NEJMoa1007994
24.
Zoungas S, Galan BE de, Ninomiya T, et al.
Combined Effects of Routine Blood Pressure Lowering
and Intensive Glucose Control on Macrovascular and Microvascular
Outcomes in Patients With Type 2 Diabetes: New results from the ADVANCE
trial. Diabetes Care [Internet] 2009;32(11):2068–74. Available
from: https://doi.org/10.2337/dc09-0959
25.
Erayil SE, Smith MK, Gebreslasse T, et al. The
value and interpretation of race and ethnicity data in the era of global
migration: A change is in order. The American Journal of Tropical
Medicine and Hygiene [Internet] 2021;105(6):1453–5. Available from: https://www.ajtmh.org/view/journals/tpmd/105/6/article-p1453.xml
26.
Andersen GS, Kamper-Jørgensen Z, Carstensen B,
Norredam M, Bygbjerg IC, Jørgensen ME. Diabetes among migrants in Denmark: Incidence, mortality,
and prevalence based on a longitudinal register study of the entire
Danish population. Diabetes Res Clin Pract 2016;Dec:122:9–16.
27.
Meeks KA, Freitas-Da-Silva D, Adeyemo A, et al.
Disparities in type 2 diabetes prevalence among ethnic
minority groups resident in Europe: a systematic review and
meta-analysis. Intern Emerg Med 2016;Apr; 11(3):327-40.
28.
Holcomb WL, Chaiworapongsa T, Luke DA, Burgdorf
KD. An odd measure of risk: use and misuse of the odds
ratio. Obstetrics & Gynecology 2001;98(4):685–8.
29.
Ahlmark N, Algren MH, Holmberg T, et al. Survey nonresponse
among ethnic minorities in a national health survey – a mixed-method
study of participation, barriers, and potentials. Ethnicity &
Health 2015;20(6):611–32.
30.
Gele AA, Mbalilaki AJ. Overweight and obesity among African immigrants in
Oslo. BMC Res Notes 2013;6.
31.
Ahmed S, Meyer HE, Kj�llesdal MK, Madar MA. Prevalence and Predictors of Overweight and Obesity among
Somalis in Norway and Somaliland: A Comparative Study.
Journal of Obesity 2018;
32.
Skogberg N, Laatikainen T, Lundqvist A, Lilja
E, H�rk�nen T, Koponen P. Which anthropometric measures best indicate type 2
diabetes among Russian, Somali and Kurdish migrants in Finland? A
cross-sectional study. BMJ Open 2018;8.
33.
Ramirez-Sanchez DC, Krasnik A, Kildemoes HW. Do
immigrants from Turkey, Pakistan and Ex-Yugoslavia with newly diagnosed
type 2 diabetes initiate recommended statin therapy to the same extent
as Danish-born residents? A nationwide register study. Eur J
Clin Pharmacol 2013;69:87–95.
34.
Danmarks Statistik [Statistics Denmark]. Befolkningsfremskrivning: Indvandrere og efterkommere
[English: Population projection: Immigrants and descendants]
[Internet]. {2019-2039; last accessed on 7 Feb 2023};Available from: https://extranet.dst.dk/pyramide/pyramide.htm#!y=2039&o=2019&c=4
35.
UNHCR. “Refugees” and “Migrants” –
Frequently Asked Questions (FAQs) [Internet]. {2016; last
accessed on 7 Feb 2023};Available from: https://www.unhcr.org/en-us/news/latest/2016/3/56e95c676/refugees-migrants-frequently-asked-questions-faqs.html
36.
European Commission, Migration and Home
Affairs. Country responsible for asylum application
(Dublin Regulation) [Internet]. {last accessed on 7 Feb
2023};Available from: https://home-affairs.ec.europa.eu/policies/migration-and-asylum/common-european-asylum-system/country-responsible-asylum-application-dublin-regulation_en
37.
The
Danish Immigration Service. New to Denmark: You
want to apply for a residence and work permit as a student
[Internet]. {last accessed on 7 Feb 2023};Available from: https://nyidanmark.dk/uk-UA/You-want-to-apply/Study
38.
The
Danish Immigration Service. New to Denmark: You
want to apply as a family member [Internet]. {last accessed on 7
Feb 2023};Available from: https://nyidanmark.dk/uk-UA/You-want-to-apply/Family
39.
The
Danish Immigration Service. New to Denmark: You
want to apply for a work permit [Internet]. {last accessed on 7
Feb 2023};Available from: https://nyidanmark.dk/uk-UA/You-want-to-apply/Work
40.
The
Danish Immigration Service. New to Denmark: Nordic
citizens [Internet]. {last accessed on 7 Feb 2023};Available
from: https://nyidanmark.dk/uk-UA/You-want-to-apply/Residence-as-a-Nordic-citizen-or-EU-or-EEA-citizen/Nordic-citizens
41.
Danmarks Statistik [English: Statistics
Denmark]. Indvandrere i Danmark 2019 [English:
Immigrants in Denmark 2019] [Internet]. {2019; last accessed on 7
Feb 2023};Available from: https://www.dst.dk/Site/Dst/Udgivelser/GetPubFile.aspx?id=29446&sid=indv2019
42.
Indenrigs- og Boligministeriet [English:
Ministry of the Interior and Housing]. Vejledning
om folkeregistrering, bilag 1: Registrering af hændelser i udlandet
[English: Civil registration guidelines, appendix 1: Registration of
events abroad] [Internet]. {2013; last accessed on 7 Feb
2023};Available from: https://www.retsinformation.dk/eli/retsinfo/2013/9273#Bil1
43.
Indenrigs- og Boligministeriet [English:
Ministry of the Interior and Health]. Bekendtgørelse om tolkebistand efter sundhedsloven
[English: Executive Order on Interpretation Services under the Health
Care Act] [Internet]. {2018; last accessed on 7 Feb
2023};Available from: https://www.retsinformation.dk/eli/lta/2018/855
44.
Danmarks Statistik [English: Statistics
Denmark]. Indvandrernes medbragte uddannelse
[English: Education carried by immigrants] [Internet]. {2020;
last accessed on 7 Feb 2023};Available from: https://www.dst.dk/Site/Dst/SingleFiles/GetArchiveFile.aspx?fi=formid&fo=medbragt-udd--pdf
45.
Danmarks Statistik [English: Statistics
Denmark]. Fakta om indvandrere og efterkommere i
Danmark [English: Facts on immigrants and descendants in Denmark]
[Internet]. {2022; last accessed on 7 Feb 2023};Available from: https://www.dst.dk/da/Statistik/nyheder-analyser-publ/bagtal/2022/2022-08-18-fakta-om-indvandrere
46.
United Nations Statistics Division. Standard country or area codes for statistical use
(M49) [Internet]. {2022; last accessed on 7 Feb 2023};Available
from: https://unstats.un.org/unsd/methodology/m49/
47.
Statistics Denmark. Documentation of statistics for Population Projections
2019 [Internet]. {2019; last accessed on 7 Feb 2023};Available
from: https://www.dst.dk/Site/Dst/SingleFiles/GetArchiveFile.aspx?fi=49459100303&fo=0&ext=kvaldel
48.
Kaneshiro B, Geling O, Gellert K, Millar L. The
challenges of collecting data on race and ethnicity in a diverse,
multiethnic state. Hawaii Med J 2011;70(8):168–71.
49.
Bennet L, Udumyan R, Östgren CJ, Rolandsson O,
Jansson SPO, Wändell P. Mortality in first-
and second-generation immigrants to sweden diagnosed with type 2
diabetes: A 10 year nationwide cohort study. Diabetologia
2021;64(1):95–108.
50.
Vandenheede H, Deboosere P, Stirbu I, et al. Migrant mortality from diabetes mellitus across Europe:
the importance of socio-economic change. Eur J Epidemiol
2012;Feb; 27(2):109-17.
51.
Holm AL, Andersen GS, Diderichsen F, Jørgensen
ME. Is the Rule of Halves framework relevant for diabetes
care in Copenhagen today? A register-based cross-sectional
study. BMJ Open 2018;8:e023211.
52.
Kristensen J, Bak J, Wittrup I, Lauritzen T. Diabetes prevalence and quality of diabetes care among
Lebanese or Turkish immigrants compared to a native Danish
population. Prim Care Diabetes 2007;Sep:1(3):159–65.
53.
Whyte MB, Hinton W, McGovern A, et al. Disparities in glycaemic control, monitoring, and
treatment of type 2 diabetes in England: A retrospective cohort
analysis. PLoS Med 2019;Oct 7; 16(10):e1002942.
54.
Tran AT, Diep LM, Cooper JG, et al. Quality of care for patients with type 2 diabetes in
general practice according to patients’ ethnic background: a
cross-sectional study from Oslo, Norway. BMC Health Serv Res
2010;10, 145.
55.
Rawshani A, Svensson A, Rosengren A, Zethelius
B, Eliasson B, Gudbjörnsdottir S. Impact of ethnicity on progress of glycaemic control in
131935 newly diagnosed patients with type 2 diabetes: a nationwide
observational study from the Swedish National Diabetes
Register. BMJ Open 2015;5;e007599.
56.
Marchesini G, Bernardi D, Miccoli R, et al. Under-treatment of migrants with diabetes in a
universalistic health care system: The ARNO Observatory. Nutr
Metab Cardiovasc Dis 2014;24.
57.
Knudsen ST, Bodegård J, Birkeland KI, et al. Risk factor management of type 2 diabetic patients in
primary care in the Scandinavian countries between 2003 and
2015. Primary Care Diabetes 2021;15:262–8.
58.
Nielsen SS, Hempler NF, Waldorff FB, Kreiner S,
Krasnik A. Is there equity in use of healthcare services among
immigrants, their descendents, and ethnic Danes? Scandinavian
Journal of Public Health 2012;40:260–70.
59.
Wieland ML, Morrison TB, Cha SS, Rahman AS,
Chaudhry R. Diabetes Care Among Somali Immigrants and
Refugees. J Community Health 2012;37:680–4.
60.
Negandhi PH, Ghouri N, Colhoun HM, et al. Ethnic Differences in Glycaemic Control in People with
Type 2 Diabetes Mellitus Living in Scotland. PLoS ONE 2013;8.
61.
Eastwood SV, Mathur R, Sattar N, Smeeth L,
Bhaskaran K, Chaturvedi N. Ethnic differences in guideline-indicated statin
initiation for people with type 2 diabetes in UK primary care,
2006-2019: A cohort study. PLoS Med 2021;18.
62.
Marzona I, Avanzini F, Tettamanti M, et al. Prevalence and management of diabetes in immigrants
resident in the Lombardy Region: the importance of ethnicity and
duration of stay. Acta Diabetol 2018;55:355–62.
63.
Nicolucci A, Greenfield S, Mattke S. Selecting indicators for the quality of diabetes care at
the health systems level in OECD countries. International Journal
for Quality in Health Care [Internet] 2006;18(suppl_1):26–30. Available
from: https://doi.org/10.1093/intqhc/mzl023
64.
Jørgensen ME, Kristensen JK, Reventlov Husted
G, Cerqueira C, Rossing P. The danish adult diabetes registry. Clinical
epidemiology [Internet] 2016;8:429–34. Available from: https://www.ncbi.nlm.nih.gov/pubmed/27843339
https://www.ncbi.nlm.nih.gov/pmc/PMC5098513/
65.
Danish Medicines Agency. Reimbursement thresholds [Internet]. {2023; last
accessed on 7 Feb 2023};Available from: https://laegemiddelstyrelsen.dk/en/reimbursement/calculate-reimbursement/reimbursement-thresholds/
66.
Danish Regions. OKPortal:
Takstmapper [English: Contract agreement Portal: Rate folders]
[Internet]. {2023; last accessed on 7 Feb 2023};Available from: https://okportal.dk/Default.aspx?area=Praksis&type=Takstmapper
67.
Schmidt M, Schmidt SAJ, Adelborg K, et al. The danish health care
system and epidemiological research: From health care contacts to
database records. Clin Epidemiol 2019;11:563–91.
68.
Eurostat. Glossary:
Equivalised disposable income [Internet]. {last accessed 7 Feb
2023};Available from: https://ec.europa.eu/eurostat/statistics-explained/index.php?title=Glossary:Equivalised_disposable_income
69.
World Health Organisation. International statistical classification of diseases and
related health problems, 10th revision: Instruction manual, fifth
edition [Internet]. {2016, last accessed 7 Feb 2023};Available
from: https://icd.who.int/browse10/Content/statichtml/ICD10Volume2_en_2019.pdf
70.
World Health Organization. Use of glycated haemoglobin (HbA1c) in diagnosis of
diabetes mellitus: abbreviated report of a WHO consultation
[Internet]. {2011; last accessed on 12 Jan 2022};WHO/NMH/CHP/CPM/11.1.
Available from: https://apps.who.int/iris/handle/10665/70523
71.
Anders Aasted Isaksen. The Open-Source
Diabetes Classifier [Internet]. {last accessed 7 Feb
2023};Available from: https://github.com/Aastedet/osdc
72.
Sundhedsdatastyrelsen [English: Danish Health
Data Authority]. Dokumentation af
Laboratoriedatabasens Forskertabel – Version 1.3 [English: Documentation
on Register of Laboratory Results for Research - version 1.3]
[Internet]. {2018, last accessed 7 Feb 2023};Available from: https://sundhedsdatastyrelsen.dk/-/media/sds/filer/registre-og-services/nationale-sundhedsregistre/doedsaarsager-og-biologisk-materiale/laboratoriedatabasen/dokumentation-af-labdatabasens-forskertabel.pdf
73.
Sundhedsdatastyrelsen [English: Danish Health
Data Authority]. Algoritmer for udvalgte kroniske
sygdomme og svære psykiske lidelser [English: Algorithms for selected
chronic diseases and serious mental illnesses] [Internet]. {2016,
last accessed 7 Feb 2023};Available from: https://www.esundhed.dk/-/media/Files/Dokumentation/Register-for-Udvalgte-Kroniske-Sygdomme-og-Svaere-Psykiske-Lidelser/29_Algoritmer_for_RUKS.ashx
74.
Sundhedsdatastyrelsen [English: Danish Health
Data Authority]. Algoritmer for udvalgte kroniske
sygdomme og svære psykiske lidelser [English: Algorithms for selected
chronic diseases and serious mental illnesses] [Internet]. {2022,
last accessed 7 Feb 2023};Available from: https://www.esundhed.dk/-/media/Files/Publikationer/Emner/Operationer-og-diagnoser/Udvalgte-kroniske-sygdomme-svaere-psykiske-lidelser/Algoritmer-for-Udvalgte-Kroniske-Sygdomme-og-svre-psykiske-lidelser-RUKS-2022.ashx
75.
Carstensen B, Kristensen JK, Marcussen MM,
Borch-Johnsen K. The
national diabetes register. Scand J Public Health 2011;39(7
Suppl):58–61.
76.
Green A, Sortsø C, Jensen PB, Emneus M.
Validation of the danish national diabetes register. Clinical
epidemiology [Internet] 2014;7:5–15. Available from: https://www.ncbi.nlm.nih.gov/pubmed/25565889
https://www.ncbi.nlm.nih.gov/pmc/PMC4274151/
77.
Wertheimer AI. The defined daily dose system
(DDD) for drug utilization review. Hosp Pharm 1986;21(3):233–4, 239–41,
258.
78.
Bjerg L, Dalsgaard E-M, Norman K, Isaksen AA,
Sandbæk A. Cohort profile: Health in central denmark (HICD) cohort - a
register-based questionnaire survey on diabetes and related
complications in the central denmark region. BMJ Open [Internet]
2022;12(7):e060410. Available from: http://bmjopen.bmj.com/content/12/7/e060410.abstract
79.
Christensen AI, Ekholm O, Glümer C, et al. The
danish national health survey 2010. Study design and respondent
characteristics. Scandinavian Journal of Public Health [Internet]
2012;40(4):391–7. Available from: https://doi.org/10.1177/1403494812451412
80.
R
Core Team. R: A language and environment for statistical computing
[Internet]. Vienna, Austria: R Foundation for Statistical Computing;
2020. Available from: https://www.R-project.org/
81.
RStudio Team. RStudio: Integrated development
environment for r [Internet]. Boston, MA: RStudio, PBC; 2021. Available
from: http://www.rstudio.com/
82.
Dowle M, Srinivasan A. Data.table: Extension of
‘data.frame‘ [Internet]. 2021. Available from: https://CRAN.R-project.org/package=data.table
83.
Carstensen B, Plummer M, Laara E, Hills M.
Epi: A package for statistical analysis in epidemiology
[Internet]. 2021. Available from: https://CRAN.R-project.org/package=Epi
84.
Harrison E, Drake T, Ots R. Finalfit: Quickly
create elegant regression results tables and plots when modelling
[Internet]. 2021. Available from: https://CRAN.R-project.org/package=finalfit
85.
Wickham H, Averick M, Bryan J, et al. Welcome to the tidyverse. Journal of Open Source Software
2019;4(43):1686.
86.
Halekoh U, Højsgaard S, Yan J. The r package
geepack for generalized estimating equations. Journal of Statistical
Software 2006;15/2:1–11.
87.
Iannone R. DiagrammeR: Graph/network
visualization [Internet]. 2020. Available from: https://CRAN.R-project.org/package=DiagrammeR
88.
Frerebeau N. Khroma: Colour schemes for
scientific data visualization [Internet]. Pessac, France: Université
Bordeaux Montaigne; 2021. Available from: https://doi.org/10.5281/zenodo.1472077
89.
90.
Williamson T, Eliasziw M, Fick GH. Log-binomial
models: Exploring failed convergence. Emerging Themes in Epidemiology
[Internet] 2013;10(1):14. Available from: https://doi.org/10.1186/1742-7622-10-14
91.
Chen W, Qian L, Shi J, Franklin M. Comparing
performance between log-binomial and robust poisson regression models
for estimating risk ratios under model misspecification. BMC Medical
Research Methodology [Internet] 2018;18(1):63. Available from: https://doi.org/10.1186/s12874-018-0519-5
92.
Zou
G. A
Modified Poisson Regression Approach to Prospective Studies with Binary
Data. American Journal of Epidemiology 2004;159:702–6.
93.
Greenland, Sander. Model-based Estimation of Relative Risks and Other
Epidemiologic Measures in Studies of Common Outcomes and in Case-Control
Studies. American Journal of Epidemiology 2004;160(4):301–5.
94.
Zeileis, Achim and Kleiber, Christian and
Jackman, Simon. Regression Models for Count Data in
R [Internet]. {last accessed 7 Feb 2023};Available from: https://cran.r-project.org/web/packages/pscl/vignettes/countreg.pdf
95.
Helsedirektoratet [English: Norwegian
Directorate of Health]. Nasjonal faglig
retningslinje for diabetes [English: National professional guideline for
diabetes] [Internet]. {2016, latest revision March
2021};Available from: https://www.helsedirektoratet.no/retningslinjer/diabetes
96.
National Institute for Health and Care
Excellence. NICE guideline [NG28]: Type 2 diabetes
in adults: management [Internet]. {2015, latest revision June
2022};Available from: https://www.nice.org.uk/guidance/ng28
97.
Socialstyrelsen [English: The National Board of
Health and Welfare]. Nationella riktlinjer för
diabetesvård [English: National guidelines for diabetes care]
[Internet]. 2018;Available from: https://www.socialstyrelsen.se/kunskapsstod-och-regler/regler-och-riktlinjer/nationella-riktlinjer/riktlinjer-och-utvarderingar/diabetes/
98.
Nederlands Huisarten Genootschap [English:
Dutch College of General Practitioners]. NHG
STANDARD: Diabetes mellitus type 2 [Internet]. {2018, latest
revision January 2023};Available from: https://richtlijnen.nhg.org/standaarden/diabetes-mellitus-type-2
99.
Nationale VersorgungsLeitlinie [English:
National Care Guidelines]. NVL Typ-2-Diabetes [Internet].
2021;Available from: https://www.leitlinien.de/themen/diabetes/2-auflage/
100.
Danish Ophthalmological Society. National retningslinje for screening for diabetisk
retinopati [English: National guideline on screening for diabetic
retinopathy] [Internet]. {2018; last accessed on 7 Feb
2023};Available from: https://dansk-oftalmologisk-selskab.dk/wp-content/uploads/2021/05/National-retningslinje-for-screening-af-diabetisk-retinopati.pdf
101.
Tan X, Yang L, Khunti K, et al. Factors
associated with switching from sulphonylureas to dipeptidyl peptidase 4
inhibitors among patients with type 2 diabetes in the united states.
Diabetes, Obesity and Metabolism [Internet] 2021;23(10):2251–60.
Available from: https://dom-pubs.onlinelibrary.wiley.com/doi/abs/10.1111/dom.14466
102.
Carney G, Kim JD, O’Sullivan C, et al.
Treatment pattern trends of medications for type 2 diabetes in british
columbia, canada. BMJ Open Diabetes Research and Care [Internet]
2022;10(6). Available from: https://drc.bmj.com/content/10/6/e002995
103.
Agyemang C, Linden EL van der, Bennet L. Type 2
diabetes burden among migrants in europe: Unravelling the causal
pathways. Diabetologia [Internet] 2021;64(12):2665–75. Available from:
https://doi.org/10.1007/s00125-021-05586-1
104.
Stephens JW, Brown KE, Min T. Chronic kidney
disease in type 2 diabetes: Implications for managing glycaemic control,
cardiovascular and renal risk. Diabetes, Obesity and Metabolism
[Internet] 2020;22(S1):32–45. Available from: https://dom-pubs.onlinelibrary.wiley.com/doi/abs/10.1111/dom.13942
105.
Kim K, Unni S, Brixner DI, et al. Longitudinal
changes in glycated haemoglobin following treatment intensification
after inadequate response to two oral antidiabetic agents in patients
with type 2 diabetes. Diabetes, Obesity and Metabolism [Internet]
2019;21(7):1725–33. Available from: https://dom-pubs.onlinelibrary.wiley.com/doi/abs/10.1111/dom.13694
106.
Bonnet F, Chen H, Cooper A, et al. What are the
factors associated with long-term glycaemic control in patients with
type 2 diabetes and elevated glycated haemoglobin (≥7.0. Diabetes,
Obesity and Metabolism [Internet] 2021;23(10):2336–43. Available from:
https://dom-pubs.onlinelibrary.wiley.com/doi/abs/10.1111/dom.14476
107.
Mathur R, Farmer RE, Eastwood SV, Chaturvedi N,
Douglas I, Smeeth L. Ethnic disparities
in initiation and intensification of diabetes treatment in adults with
type 2 diabetes in the UK, 1990-2017: A cohort study. PLoS Med
2020;17(5):e1003106.
108.
Vasti EC, Basina M, Calma J, Maron DJ,
Rodriguez F, Sandhu AT. Disparities in adoption of new diabetic
therapies with cardiovascular benefits. Diabetes Research and Clinical
Practice [Internet] 2022;110233. Available from: https://www.sciencedirect.com/science/article/pii/S0168822722010476
109.
Morton JI, Ilomӓki J, Magliano DJ, Shaw JE. The
association of socioeconomic disadvantage and remoteness with receipt of
type 2 diabetes medications in australia: A nationwide registry study.
Diabetologia [Internet] 2021;64(2):349–60. Available from: https://doi.org/10.1007/s00125-020-05304-3
110.
Elhussein A, Anderson A, Bancks MP, et al. Racial/ethnic and
socioeconomic disparities in the use of newer diabetes medications in
the look AHEAD study. Lancet Reg Health Am 2022;6.
111.
Falkentoft AC, Andersen J, Malik ME, et al.
Impact of socioeconomic position on initiation of SGLT-2 inhibitors or
GLP-1 receptor agonists in patients with type 2 diabetes – a danish
nationwide observational study. The Lancet Regional Health - Europe
[Internet] 2022;14:100308. Available from: https://www.sciencedirect.com/science/article/pii/S2666776222000011
112.
Nicolucci A, Charbonnel B, Gomes MB, et al.
Treatment patterns and associated factors in 14 668 people with type 2
diabetes initiating a second-line therapy: Results from the global
DISCOVER study programme. Diabetes, Obesity and Metabolism [Internet]
2019;21(11):2474–85. Available from: https://dom-pubs.onlinelibrary.wiley.com/doi/abs/10.1111/dom.13830
113.
Nielsen AA, Christensen H, Lund ED, Christensen
C, Brandslund I, Green A. Diabetes mortality differs between registers
due to various disease definitions. Dan Med J 2014;61(5):A4840.
114.
Rawshani A, Landin-Olsson M, Svensson AM, et
al. The incidence of
diabetes among 0-34 year olds in sweden: New data and better
methods. Diabetologia 2014;57(7):1375–81.
115.
Bak JCG, Serné EH, Kramer MHH, Nieuwdorp M,
Verheugt CL. National diabetes registries: Do they make a difference?
Acta Diabetologica [Internet] 2021;58(3):267–78. Available from: https://doi.org/10.1007/s00592-020-01576-8
116.
Hallgren Elfgren I-M, Grodzinsky E, Törnvall E.
The swedish national diabetes register in clinical practice and
evaluation in primary health care. Primary Health Care Research
& Development [Internet] 2016;17(6):549–58. Available from: https://www.cambridge.org/core/article/swedish-national-diabetes-register-in-clinical-practice-and-evaluation-in-primary-health-care/F3A9B74FED1E7B36147FF63382939B9A
117.
Cooper JG, Thue G, Claudi T, Løvaas K, Carlsen
S, Sandberg S. The norwegian diabetes register for adults – an overview
of the first years. Norsk Epidemiologi [Internet] 2013;23(1). Available
from: https://www.ntnu.no/ojs/index.php/norepid/article/view/1599
118.
Marszalek RT, Flintoft L. Being open: Our
policy on source code. Genome Biology [Internet] 2016;17(1):172.
Available from: https://doi.org/10.1186/s13059-016-1040-y
119.
Dima AL, Dediu D. Computation of
adherence to medication and visualization of medication histories in r
with AdhereR: Towards transparent and reproducible use of electronic
healthcare data. PLoS One 2017;12(4):e0174426.
120.
Klompas M, Eggleston E, McVetta J, Lazarus R,
Li L, Platt R. Automated
detection and classification of type 1 versus type 2 diabetes using
electronic health record data. Diabetes Care 2013;36(4):914–21.
121.
Schroeder EB, Donahoo WT, Goodrich GK, Raebel
MA. Validation of an
algorithm for identifying type 1 diabetes in adults based on electronic
health record data. Pharmacoepidemiol Drug Saf 2018;27(10):1053–9.
122.
Lo-Ciganic W, Zgibor JC, Ruppert K, Arena VC,
Stone RA. Identifying type 1 and
type 2 diabetic cases using administrative data: A tree-structured
model. J Diabetes Sci Technol 2011;5(3):486–93.
123.
Weisman A, Tu K, Young J, et al. Validation of a type 1
diabetes algorithm using electronic medical records and administrative
healthcare data to study the population incidence and prevalence of type
1 diabetes in ontario, canada. BMJ Open Diabetes Res Care 2020;8(1).
124.
Lynam A, McDonald T, Hill A, et al. Development and
validation of multivariable clinical diagnostic models to identify type
1 diabetes requiring rapid insulin therapy in adults aged 18-50
years. BMJ Open 2019;9(9):e031586.
125.
Ke
C, Stukel TA, Luk A, et al. Development and validation of algorithms to
classify type 1 and 2 diabetes according to age at diagnosis using
electronic health records. BMC Medical Research Methodology [Internet]
2020;20(1):35. Available from: https://doi.org/10.1186/s12874-020-00921-3
126.
Thomas NJ, McGovern A, Young KG, et al.
Identifying type 1 and 2 diabetes in research datasets where
classification biomarkers are unavailable: Assessing the accuracy of
published approaches. J Clin Epidemiol [Internet] 2022;Available from:
https://www.ncbi.nlm.nih.gov/pubmed/36368478
127.
Thomas NJ, Lynam AL, Hill AV, et al. Type 1 diabetes defined
by severe insulin deficiency occurs after 30 years of age and is
commonly treated as type 2 diabetes. Diabetologia
2019;62(7):1167–72.
128.
Lim L-L, Lau ESH, Cheung JTK, et al. Real-world
usage of sulphonylureas in asian patients with type 2 diabetes using the
joint asia diabetes evaluation (JADE) register. Diabetes, Obesity and
Metabolism [Internet] 2023;25(1):208–21. Available from: https://dom-pubs.onlinelibrary.wiley.com/doi/abs/10.1111/dom.14865
129.
Lamprea-Montealegre JA, Madden E, Tummalapalli
SL, et al. Association
of race and ethnicity with prescription of SGLT2 inhibitors and GLP1
receptor agonists among patients with type 2 diabetes in the veterans
health administration system. Jama 2022;328(9):861–71.
130.
Bidulka P, Mathur R, Lugo-Palacios DG, et al.
Ethnic and socioeconomic disparities in initiation of second-line
antidiabetic treatment for people with type 2 diabetes in england: A
cross-sectional study. Diabetes, Obesity and Metabolism [Internet]
2023;25(1):282–92. Available from: https://dom-pubs.onlinelibrary.wiley.com/doi/abs/10.1111/dom.14874
131.
Li
P, Zhang P, Guan D, et al. Changes in racial and ethnic
disparities in glucose-lowering drug utilization and glycated
haemoglobin A1c in US adults with diabetes: 2005-2018. Diabetes Obes
Metab 2023;25(2):516–25.
132.
Dor A, Encinosa W. How does cost-sharing affect
drug purchases? Insurance regimes in the private market for prescription
drugs. National Bureau of Economic Research Working Paper Series
[Internet] 2004;No. 10738. Available from: http://www.nber.org/papers/w10738
133.
McManus P, Donnelly N, Henry D, Hall W,
Primrose J, Lindner J. Prescription
drug utilization following patient co-payment changes in australia.
Pharmacoepidemiol Drug Saf 1996;5(6):385–92.
134.
Khan H, Lasker SS, Chowdhury TA. Prevalence and
reasons for insulin refusal in bangladeshi patients with poorly
controlled type 2 diabetes in east london. Diabet Med
2008;25(9):1108–11.
135.
Hu
J, Amirehsani KA, Wallace DC, Letvak S. The meaning of insulin to
hispanic immigrants with type 2 diabetes and their families. The
Diabetes Educator [Internet] 2012;38(2):263–70. Available from: https://journals.sagepub.com/doi/abs/10.1177/0145721712437559
136.
Mull DS, Nguyen N, Mull JD. Vietnamese diabetic
patients and their physicians: What ethnography can teach us. West J
Med 2001;175(5):307–11.